| T-Cell Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived140 of 140show fewer |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 85 trials (25 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 85 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall_molecule 55 trials (12 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall_molecule 51 trials (8 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 40 trials (10 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall_molecule 40 trials (15 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall_molecule 40 trials (14 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall_molecule 39 trials (11 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall_molecule 34 trials (7 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 33 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 30 trials (9 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall_molecule 27 trials (4 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 26 trials (6 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 26 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 23 trials (5 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 22 trials (5 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall_molecule 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 21 trials (11 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 20 trials (13 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall_molecule 20 trials (8 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 18 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall_molecule 15 trials (5 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall_molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mechlorethaminesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall_molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CHOP Regimen 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall_molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tofacitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aminolevulinic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlormethinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daromun 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elranatamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HyperCVAD Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Molibresibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onalespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ropeginterferon Alfa-2bother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |